Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review.

Humans Cost-Benefit Analysis Public Health Surveillance Whole Genome Sequencing / methods Disease Outbreaks Public Health Cross Infection

Journal

The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 01 03 2023
revised: 31 05 2023
accepted: 05 06 2023
medline: 6 11 2023
pubmed: 9 9 2023
entrez: 8 9 2023
Statut: ppublish

Résumé

Whole-genome sequencing (WGS) has resulted in improvements to pathogen characterisation for the rapid investigation and management of disease outbreaks and surveillance. We conducted a systematic review to synthesise the economic evidence of WGS implementation for pathogen identification and surveillance. Of the 2285 unique publications identified through online database searches, 19 studies met the inclusion criteria. The economic evidence to support the broader application of WGS as a front-line pathogen characterisation and surveillance tool is insufficient and of low quality. WGS has been evaluated in various clinical settings, but these evaluations are predominantly investigations of a single pathogen. There are also considerable variations in the evaluation approach. Economic evaluations of costs, effectiveness, and cost-effectiveness are needed to support the implementation of WGS in public health settings.

Identifiants

DOI: 10.1016/S2666-5247(23)00180-5 PMID: 37683688
pubmed: 37683688
pii: S2666-5247(23)00180-5
doi: 10.1016/S2666-5247(23)00180-5
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e953-e962

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests This work was funded by the National Health and Medical Research Council (NHMRC) through the Medical Research Future Fund: the AusPathoGen Program (funding number FSPGN000049). MDK was supported by an NHMRC fellowship (GNT 1145997). All other authors declare no competing interests.

Auteurs

My Tran (M)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia. Electronic address: my.tran@anu.edu.au.

Kayla S Smurthwaite (KS)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia.

Son Nghiem (S)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia.

Danielle M Cribb (DM)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia.

Alireza Zahedi (A)

Public Health Microbiology, Forensic and Scientific Services, Queensland Health, Brisbane QLD, Australia.

Angeline D Ferdinand (AD)

Microbiological Diagnostic Unit, Peter Doherty Institute, University of Melbourne, Melbourne VIC, Australia.

Patiyan Andersson (P)

Microbiological Diagnostic Unit, Peter Doherty Institute, University of Melbourne, Melbourne VIC, Australia.

Martyn D Kirk (MD)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia.

Kathryn Glass (K)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia.

Emily Lancsar (E)

National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Economic evaluations of whole-genome...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › Economic evaluations of whole-genome...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Surveillance de la population › Surveillance de la santé publique › Economic evaluations of whole-genome...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Séquençage du génome entier › Economic evaluations of whole-genome...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Economic evaluations of whole-genome...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Economic evaluations of whole-genome...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie iatrogène › Infection croisée › Economic evaluations of whole-genome...